股市无情我有情
liked
Today's freshly released PENTA performance, both revenue and profits, are at historical highs. If you look closely, in the past two quarters, PENTA's revenue has exceeded VITROX, the leader of ATE, but the margin is not as good.
During the 2020 epidemic, PENTA faced many challenges, with engineers unable to install at customer factories, causing transportation issues. However, these are transitional periods, with the company's revenue breaking historical highs for 3 consecutive years from 2021 to 2023.
While others are still striving for recovery, PENTA has been constantly achieving new highs. This is mainly because PENTA foresaw the slowdown of the smart phone industry a few years ago, so it deployed IGBT and SiC businesses. The latest quarter's automotive business accounted for more than 60% for the first time, which is the main reason for the company's successful comeback.
PENTA's Plant 3 is expected to complete Phase 1 by the end of the year, and Phase 2 will be completed in the second half of 2024. The expansion in the first half of this year exceeded RM40 million, reaching a historical high. This expansion is mainly to grow the Medical business, stimulating revenue growth, and aiming to achieve the target of breaking RM1,000 million in revenue by 2025.
Looking forward to PENTA getting better and better, and looking forward to the rise of PENTA in Hong Kong.
During the 2020 epidemic, PENTA faced many challenges, with engineers unable to install at customer factories, causing transportation issues. However, these are transitional periods, with the company's revenue breaking historical highs for 3 consecutive years from 2021 to 2023.
While others are still striving for recovery, PENTA has been constantly achieving new highs. This is mainly because PENTA foresaw the slowdown of the smart phone industry a few years ago, so it deployed IGBT and SiC businesses. The latest quarter's automotive business accounted for more than 60% for the first time, which is the main reason for the company's successful comeback.
PENTA's Plant 3 is expected to complete Phase 1 by the end of the year, and Phase 2 will be completed in the second half of 2024. The expansion in the first half of this year exceeded RM40 million, reaching a historical high. This expansion is mainly to grow the Medical business, stimulating revenue growth, and aiming to achieve the target of breaking RM1,000 million in revenue by 2025.
Looking forward to PENTA getting better and better, and looking forward to the rise of PENTA in Hong Kong.
Translated
42
2